These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 20663964

  • 1. Effect of repetitive arm cycling following botulinum toxin injection for poststroke spasticity: evidence from FMRI.
    Diserens K, Ruegg D, Kleiser R, Hyde S, Perret N, Vuadens P, Fornari E, Vingerhoets F, Seitz RJ.
    Neurorehabil Neural Repair; 2010 Oct; 24(8):753-62. PubMed ID: 20663964
    [Abstract] [Full Text] [Related]

  • 2. Modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A: an fMRI study.
    Senkárová Z, Hlustík P, Otruba P, Herzig R, Kanovský P.
    J Neuroimaging; 2010 Jan; 20(1):9-15. PubMed ID: 19453837
    [Abstract] [Full Text] [Related]

  • 3. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J, Entner T.
    Wien Klin Wochenschr; 2001 Jan; 113 Suppl 4():20-4. PubMed ID: 15506048
    [Abstract] [Full Text] [Related]

  • 4. [Experiences with botulinum toxin injections against spasticity in children].
    Ramstad K, Karstensen AB, Risberg K, Bergsaker DK, Sommer FF.
    Tidsskr Nor Laegeforen; 2006 Feb 09; 126(4):450-2. PubMed ID: 16477283
    [Abstract] [Full Text] [Related]

  • 5. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
    Jahangir AW, Tan HJ, Norlinah MI, Nafisah WY, Ramesh S, Hamidon BB, Raymond AA.
    Med J Malaysia; 2007 Oct 09; 62(4):319-22. PubMed ID: 18551937
    [Abstract] [Full Text] [Related]

  • 6. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
    Rameckers EA, Speth LA, Duysens J, Vles JS, Smits-Engelsman BC.
    Neurorehabil Neural Repair; 2009 Oct 09; 23(3):218-25. PubMed ID: 19106252
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin injection of the subscapularis muscle.
    Unlu E, Sen T, Umay E, Bal B, Elhan A, Cakci A.
    J Clin Neurosci; 2010 Oct 09; 17(10):1265-6. PubMed ID: 20591673
    [Abstract] [Full Text] [Related]

  • 8. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J, Bogucki A, Reclawowicz D.
    Neurol Sci; 2005 Apr 09; 26(1):32-9. PubMed ID: 15877185
    [Abstract] [Full Text] [Related]

  • 9. BoNT-A related changes of cortical activity in patients suffering from severe hand paralysis with arm spasticity following ischemic stroke.
    Veverka T, Hluštík P, Tomášová Z, Hok P, Otruba P, Král M, Tüdös Z, Zapletalová J, Herzig R, Krobot A, Kaňovský P.
    J Neurol Sci; 2012 Aug 15; 319(1-2):89-95. PubMed ID: 22687958
    [Abstract] [Full Text] [Related]

  • 10. Cortical activity modulation by botulinum toxin type A in patients with post-stroke arm spasticity: real and imagined hand movement.
    Veverka T, Hluštík P, Hok P, Otruba P, Tüdös Z, Zapletalová J, Krobot A, Kaňovský P.
    J Neurol Sci; 2014 Nov 15; 346(1-2):276-83. PubMed ID: 25255982
    [Abstract] [Full Text] [Related]

  • 11. Does low-dose botulinum toxin help the recovery of arm function when given early after stroke? A phase II randomized controlled pilot study to estimate effect size.
    Cousins E, Ward A, Roffe C, Rimington L, Pandyan A.
    Clin Rehabil; 2010 Jun 15; 24(6):501-13. PubMed ID: 20483887
    [Abstract] [Full Text] [Related]

  • 12. Botulinum toxin in post-stroke patients: stiffness modifications and clinical implications.
    Miscio G, Del Conte C, Pianca D, Colombo R, Panizza M, Schieppati M, Pisano F.
    J Neurol; 2004 Feb 15; 251(2):189-96. PubMed ID: 14991354
    [Abstract] [Full Text] [Related]

  • 13. Functional and clinical changes in upper limb spastic patients treated with botulinum toxin (BTX).
    Panizza M, Castagna M, di Summa A, Saibene L, Grioni G, Nilsson J.
    Funct Neurol; 2000 Feb 15; 15(3):147-55. PubMed ID: 11062843
    [Abstract] [Full Text] [Related]

  • 14. Motor control testing of upper limb function after botulinum toxin injection: a case study.
    Hurvitz EA, Conti GE, Flansburg EL, Brown SH.
    Arch Phys Med Rehabil; 2000 Oct 15; 81(10):1408-15. PubMed ID: 11030508
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of high-frequency repetitive transcranial magnetic stimulation over ipsilesional primary motor cortex in cortical and subcortical middle cerebral artery stroke.
    Ameli M, Grefkes C, Kemper F, Riegg FP, Rehme AK, Karbe H, Fink GR, Nowak DA.
    Ann Neurol; 2009 Sep 15; 66(3):298-309. PubMed ID: 19798637
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
    Fève A, Decq P, Filipetti P, Kéravel Y.
    Neurochirurgie; 1998 Sep 15; 44(3):192-6. PubMed ID: 9827435
    [Abstract] [Full Text] [Related]

  • 17. Combined therapy using botulinum toxin A and single-joint hybrid assistive limb for upper-limb disability due to spastic hemiplegia.
    Saita K, Morishita T, Hyakutake K, Fukuda H, Shiota E, Sankai Y, Inoue T.
    J Neurol Sci; 2017 Feb 15; 373():182-187. PubMed ID: 28131185
    [Abstract] [Full Text] [Related]

  • 18. Botulinum toxin to treat upper-limb spasticity in hemiparetic patients: analysis of function and kinematics of reaching movements.
    Bensmail D, Robertson JV, Fermanian C, Roby-Brami A.
    Neurorehabil Neural Repair; 2010 Feb 15; 24(3):273-81. PubMed ID: 20067949
    [Abstract] [Full Text] [Related]

  • 19. Botulinum neurotoxin intramuscular chemodenervation. Role in the management of spastic hypertonia and related motor disorders.
    Yablon SA.
    Phys Med Rehabil Clin N Am; 2001 Nov 15; 12(4):833-74, vii-viii. PubMed ID: 11723867
    [Abstract] [Full Text] [Related]

  • 20. Variability and predictability of functional efficacy of botulinum toxin injection in leg spastic muscles.
    Rousseaux M, Compère S, Launay MJ, Kozlowski O.
    J Neurol Sci; 2005 May 15; 232(1-2):51-7. PubMed ID: 15850582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.